Version: 01 November 2022
You are welcome to request our FAQ catalog on the IVDR topic from us. In it, we provide detailed answers to relevant questions.
Please contact us at immunhistochemie@zytomed-systems.de.
A recently conducted study has shown that TRPS1 is expressed very highly in triple-negative breast cancer (TNBC). Expression was significantly higher than the GATA3 expression in metaplastic (85% vs. 21%) and non-metaplastic (86% vs. 51%) TNBC. Accordingly, TRPS1 has proven to be a highly specific and sensitive marker for all types of breast cancer, in particular TNBC. (Di Ai et al.; "TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer. Mod Pathol 34: 710-719, 2021)
Anhaltinerstraße 16
14163 Berlin
+49 30-804 984 990
+49 30-804 984 999
info@zytomed-systems.de
Intensive consulting and individual support. Anytime and anywhere.
Customer Support
030-804 984 990
Technical support
+49 30-23 59 67 500
Laboratory Hotline
+49 30-810 542 690
Currently, we do not have the capacity to produce customized antibodies. We are happy to put you in touch with reliable partners. You can contact us via phone +49 30 804 984 990 or via mail to info@zytomed-systems.de.
IThe technical datasheet of every antibody lists the tested reactivity of the antibody. This does not mean that the antibody does not react with species not listed, but that they have not been verified. If the desired reactivity of the antibody is not listed, please contact us via phone +49 30 804 984 990 or via mail to info@zytomed-systems.de. We are happy to check if the antibody is suitable for your application.
Delivery is on account and at the costs of the purchaser.
The delivery time for our products is about 5 to 15 days.
A mercury-vapor lamp (100 Watt) is optimally suited for FISH.
